Pharmacy is no longer the fastest-growing non-labor expense in healthcare.
According to Vizient’s “Winter 2026 Spend Management Outlook,” released Feb. 3, overall healthcare supply chain inflation of 2.78% is projected from July 2026 through June 2027, with IT, facilities and purchased services now outpacing pharmacy in cost growth. Pharmacy price inflation is expected to moderate to 2.84%, down from 3.35% six months ago, driven by biosimilar adoption and early impacts of Medicare drug price negotiations under the Inflation Reduction Act.
IT hardware and software top the inflation forecast at 5.66%, followed by medical gases at 5%, IT services at 4.5%, facilities management at 4.13% and food at 3.63%. Vizient said these categories reflect growing investment in digital infrastructure, cybersecurity and regulatory compliance.
The report also cited a 24% increase in radiopharmaceutical utilization between 2023 and 2024, with theranostic-related capital investment expected to grow another 24% in 2025. GLP-1 therapies continue to reshape demand, with bariatric surgery volumes down 20% since 2022 and further site-of-care shifts anticipated, the report said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.